Clinical question
Most treatment plans include baseline testing, repeat labs after a dose or formulation change, and periodic monitoring once stable. Timing varies by medication, symptoms, risk factors, and guideline; a common pattern is an early follow-up around 6–8 weeks and stable monitoring about every 6 months.
Condition guide
Possible symptoms include reduced libido, erectile difficulty, low energy, depressed mood, reduced muscle mass, and infertility, but these symptoms have many causes. Diagnosis requires compatible symptoms plus consistently low morning testosterone on properly collected repeat testing, interpreted by a clinician.
Compound profile
TRT ester overview, half-life, injection schedules, monitoring, and clinical questions.
Guide
A practical overview of testosterone replacement therapy, evaluation, monitoring, and risks.
Protocol
What common hormone and metabolic labs measure and how timing affects interpretation.
Comparison
HCG acts like luteinizing hormone at the testes, while enclomiphene is a selective estrogen receptor modulator that can increase pituitary LH and FSH signaling. The choice depends on the treatment goal, fertility status, laboratory findings, and clinician supervision.
Condition guide
First confirm the result with a sensitive male estradiol assay and assess symptoms, testosterone dose, injection pattern, body composition, medications, and other causes. Do not automatically add an aromatase inhibitor based on a single number; discuss the result with the prescribing clinician.
Guide
Foundational guide to male hormones, symptoms, testing, and clinical interpretation.
Condition guide
Exogenous testosterone can suppress LH and FSH, reducing intratesticular testosterone and sperm production. Some men pursue fertility-preservation strategies, but there is no universal guarantee; semen analysis and reproductive-endocrinology guidance are important before and during treatment.